Nomogram model based on γ-glutamyl transferase to albumin ratio predicts survival in hepatocellular carcinoma patients with transarterial chemoembolization treatment

doi:10.4251/wjgo.v16.i12.4650

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (848)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

HTML

463

Figures (1-5)

102

Tables (1-4)

Sum=670

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

120

Sum=149

Dec 15, 2024 (publication date) through Jan 30, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4650-4662
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4650

Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival curves stratified by γ-glutamyl transferase to albumin ratio. A: Overall survival of the transarterial chemoembolization alone cohort; B: The cohort after propensity score matching; C: Training set; D: Validation set; E: Dual therapy cohort; F: Triple therapy cohort. GAR: γ-glutamyl transferase to albumin ratio.

Citation: Wu ZY, Li H, Chen JL, Su K, Weng ML, Han YW. Nomogram model based on γ-glutamyl transferase to albumin ratio predicts survival in hepatocellular carcinoma patients with transarterial chemoembolization treatment. World J Gastrointest Oncol 2024; 16(12): 4650-4662
URL: https://www.wjgnet.com/1948-5204/full/v16/i12/4650.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i12.4650